1-Methylnicotinamide (chloride)

1-Methylnicotinamide (chloride) (CAS No.: 1005-24-9) is an endogenous metabolite derived from nicotinamide metabolism and is widely recognized as a bioactive small molecule in cardiovascular and inflammatory research. It functions as a modulator of cellular signaling pathways and enzymatic processes, contributing to vascular homeostasis and immune regulation. Experimental studies have demonstrated that 1-methylnicotinamide exerts antithrombotic and anti-inflammatory effects, potentially through mechanisms involving endothelial function improvement, modulation of nitric oxide bioavailability, and attenuation of pro-inflammatory signaling cascades. Although precise molecular targets remain incompletely defined, its activity is associated with regulation of pathways linked to platelet aggregation and inflammatory mediator production, with observed effects typically occurring in the low micromolar to millimolar concentration range depending on the model system. This compound is frequently utilized in in vitro cell-based assays and in vivo models of thrombosis and inflammation to investigate disease mechanisms and evaluate pharmacological modulation of vascular and immune responses, with experimental concentrations or dosing regimens tailored to specific study designs and research objectives.